Pathogenesis of Myeloproliferative Disorders.
Publication Date
2016-05-23Journal Title
Annu Rev Pathol
ISSN
1553-4006
Volume
11
Pages
101-126
Language
English
Type
Article
Metadata
Show full item recordCitation
Nangalia, J., Grinfeld, J., & Green, T. (2016). Pathogenesis of Myeloproliferative Disorders.. Annu Rev Pathol, 11 101-126. https://doi.org/10.1146/annurev-pathol-012615-044454
Abstract
Myeloproliferative neoplasms (MPNs) are a set of chronic hematopoietic neoplasms with overlapping clinical and molecular features. Recent years have witnessed considerable advances in our understanding of their pathogenetic basis. Due to their protracted clinical course, the evolution to advanced hematological malignancies, and the accessibility of neoplastic tissue, the study of MPNs has provided a window into the earliest stages of tumorigenesis. With the discovery of mutations in CALR, the majority of MPN patients now bear an identifiable marker of clonal disease; however, the mechanism by which mutated CALR perturbs megakaryopoiesis is currently unresolved. We are beginning to understand better the role of JAK2(V617F) homozygosity, the function of comutations in epigenetic regulators and spliceosome components, and how these mutations cooperate with JAK2(V617F) to modulate MPN phenotype.
Keywords
StemCellInstitute, CALR, JAK2, MPL, epigenetic, myeloproliferative neoplasms
Sponsorship
MRC (MC_PC_12009)
Identifiers
External DOI: https://doi.org/10.1146/annurev-pathol-012615-044454
This record's URL: https://www.repository.cam.ac.uk/handle/1810/252616
Rights
Licence:
http://www.rioxx.net/licenses/all-rights-reserved